Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system

Neuroscience

Volumn 124, Issue 4, 2004, Pages 831-839

  Chen, S T ^a   Chuang, J I ^a   Wang, J P ^a   Tsai, M S ^b   Li, H ^b   Chang, N S ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c GUTHRIE RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Brain; Development; Dorsal root ganglion; DRG; E; Embryonic day; p53; TNF; Tumor necrosis factor; WOX1; ww domain containing oxidoreductase

Indexed keywords

OXIDOREDUCTASE; PROTEIN P53; PROTEIN WOX1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN STEM; CHOROID PLEXUS; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; EMBRYO; EMBRYO DEVELOPMENT; ENZYME LOCALIZATION; EPENDYMA CELL; EPITHELIUM CELL; FEMALE; GENETIC TRANSCRIPTION; GERM LAYER; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MESENCHYME; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL CREST; NEWBORN; NONHUMAN; OPTIC TRACT; PERINATAL DEVELOPMENT; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL CORD; SPINAL GANGLION; WESTERN BLOTTING; WHITE MATTER; WILD TYPE;

AGING; ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN STEM; DOWN-REGULATION; EMBRYO; GANGLIA; GANGLIA, SPINAL; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; NERVE FIBERS; NERVOUS SYSTEM; OXIDOREDUCTASES; SENSE ORGANS; SPINAL CORD; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1542351221     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.12.036     Document Type: Article

References (26)

1. Bednarek A.K., Laflin K.J., Daniel R.L., Liao Q., Hawkins K.A., Aldaz C.M. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 60:2000;2140-2145.
2. Chang N.-S., Pratt N., Heath J., Schultz L., Sleve D., Carey G.B., Zevotek N. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem. 276:2001;3361-3370.
3. Chang N.-S. Transforming growth factor-β1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts. BMC Cell Biol. 3:2002;8.
4. Chang N.-S. A potential role of p53 and WOX1 in mitochondrial apoptosis. Int J Mol Med. 9:2002;19-24.
5. Chang N.-S., Doherty J., Ensign A. c-Jun N-terminal kinase 1 (JNK1) physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J Biol Chem. 278:2003;9195-9202.
6. Chang N.-S., Doherty J., Ensign A., Lewis J., Heath J., Schultz L., Chen S.T., Oppermann U. Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses. Biochem Pharmacol. 66:2003;1347-1354.
7. Chen S.T., Chuang S.M., Wang J.P. Src expression during murine development. Biomed Res. 20:1999;259-272.
8. Chen S.T., Garey L.J., Patel A.J., Malish Q., Jen L.S. Factors that affect the expression of amyloid precursor protein immunoreactivity in the rat retina. J Neuropath Exp Neurol. 57:1998;16-20.
9. + in the rat. Neurochem Int. 40:2002;169-179.
10. Delpech B., Delpech A., Bruckner G., Girard N., Maingonnat C. Hyaluronan and hyaluronectin in the nervous system. Ciba Found Symp. 143:1998;208-220.
11. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr, Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
12. Driouch K., Prydz H., Monese R., Johansen H., Lidereau R., Frengen E. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene. 21:2002;1832-1840.
13. Jacobson M. The neural crest and its derivatives Developmental neurobiology. 3rd ed:1991;Plenum Press, New York. pp 143-162.
14. Kuroki T., Trapasso F., Shiraishi T., Alder H., Mimori K., Mori M., Croce C.M. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res. 62:2002;2258-2260.
15. Lepperdinger G., Mullegger J., Kreil G. Hyal2-less active, but more versatile? Matrix Biol. 20:2001;509-514.
16. Miosge N., Schneider W., Gotz W., Herken R. The oncoproteins c-erb-B2, c-Fos and the tumor suppressor protein p53 in human embryos and fetuses. Anat Embryol. 195:1997;345-352.
17. Mullegger J., Lepperdinger G. Hyaluronan is an abundant constituent of the extracellular matrix of Xenopus embryos. Mol Reprod Dev. 61:2002;312-316.
18. Paige A.J.W., Taylor K.J., Taylor C., Hillier S.G., Farrington S., Scott D., Porteous D.J., Smyth J.F., Gabra H., Watson J.E. WWOX A candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci USA. 98:2001;11417-11422.
19. Ried K., Finnis M., Hobson L., Mangelsdorf M., Dayan S., Nancarrow J.K., Woollatt E., Kremmidiotis G., Gardner A., Venter D., Baker E., Richards R.I. Common chromosomal fragile site FRA16D sequence Identification of the for gene spanning fra16d and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet. 9:2000;1651-1663.
20. Schmid P., Lorenz A., Hameister H., Montenarh M. Expression of p53 during mouse embryogenesis. Development. 113:1991;857-865.
21. Stern C.D. Mini-review Hyaluronidases in early embryonic development. Cell Biol Int Rep. 8:1984;703-717.
22. Sze C-I, Su M, Pugazhenthi S, Jambal P, Hsu L-J, Heath J, Schultz L, Chang N-S (2004) Downregulation of WOX1 induces Tau phosphorylation at Thr231, Thr212 and Ser515/516 associated with tangles in vitro: a potential role in Alzheimer's disease. J Biol Chem, in press.
23. Toole B.P. Hyaluronan in morphogenesis. Semin Cell Dev Biol. 12:2001;79-87.
24. van Lookeren Campagne M., Gill R. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain Comparison with expression with expression of the cell cycle regulators p21waf/cip1, p27kip1, p57kip2, p16ink4a, cyclin g1, and the proto-oncogene bax. J Comp Neurol. 397:1998;181-198.
25. Yakicier M.C., Legoix P., Vaury C., Gressin L., Tubacher E., Capron F., Bayer J., Degott C., Balabaud C., Zucman-Rossi J. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Oncogene. 20:2001;5232-5238.
26. Yendamuri S., Kuroki T., Trapasso F., Henry A.C., Dumon K.R., Huebner K., Williams N.N., Kaiser L.R., Croce C.M. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res. 63:2003;878-881.